Explorez tous les épisodes du podcast Clinical Capsules - Actionable Medication Pearls in Minutes
| Titre | Date | Durée | |
|---|---|---|---|
| Walk Through Updated Guidelines for Restless Legs Syndrome | 09 Dec 2025 | 00:12:14 | |
In this episode, Rachel Cole, PharmD, walks us through the evolving landscape of restless leg syndrome management, highlighting why dopamine agonists are no longer first-line therapy and what that means for clinical practice. You’ll learn about the importance of checking for iron deficiency, practical non-drug interventions, and alternative medications like gabapentin and pregabalin. Rachel shares actionable tips for educating patients, managing tricky cases, and staying up to date with the latest sleep medicine guidelines, so you can take confident steps forward in caring for patients with RLS. This is an excerpt from our July 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Lenacapavir for HIV Pre-Exposure Prophylaxis (PrEP) | 25 Nov 2025 | 00:16:14 | |
In this episode, Rachel Cole, PharmD, explores the evolving landscape of medications for HIV pre-exposure prophylaxis (PrEP), spotlighting lenacapavir (Yeztugo)—a newly approved long-acting injectable option given just twice yearly. She walks through how it compares to oral therapies like Truvada and Descovy, plus other injectables such as cabotegravir. Rachel also offers practical guidance on identifying candidates for HIV PrEP, navigating lab requirements, and managing side effects. You’ll also hear strategies to help patients overcome cost barriers, improve adherence, and understand the importance of regular follow-up. Whether you’re supporting patients at the pharmacy counter or staying current on HIV prevention, this episode delivers timely insights for pharmacy teams and other healthcare professionals. This is an excerpt from our September 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead. 10% off a new or upgraded subscription with code cc1025 at checkout. 🎓 Student free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Diabetes Treatment Debate: Should Metformin Still Be Used First? | 08 Jul 2025 | 00:13:17 | |
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, delves into the debate about whether newer medications for Type 2 diabetes, including SGLT-2 inhibitors or GLP-1 agonists, should be used first-line instead of metformin. She examines the benefitsand drawbacks of these newer medications, including their cardiovascular and kidney benefits, side effects, and costs. This is an excerpt from our March 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Avoiding Medication Mishaps with Pet Prescriptions | 24 Jun 2025 | 00:12:53 | |
In this episode, TRC Healthcare editor, Don Weinberger, PharmD, PMSP, explores how to avoid medication mishaps with pet prescriptions. Learn about common pitfalls, species-specific risks, and best practices for pharmacists and technicians. This is an excerpt from our December 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Doxy PEP for STI Prevention | 10 Jun 2025 | 00:11:31 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses Doxycycline Post-Exposure Prophylaxis for STIs. This is an excerpt from our August 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Our listeners can get 10% off a new subscription with code podcast1025 at checkout. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Sofpironium (Sofdra) for Hyperhidrosis | 27 May 2025 | 00:13:39 | |
In this episode, TRC Healthcare editor, Gina Corley, PharmD, discusses how to treat hyperhidrosis, or excessive sweating, including the use of a drug called sofpironium or Sofdra, which is a new topical agent approved for primary axillary hyperhidrosis. This is an excerpt from our November 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter.
Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Tailoring Contraceptive Use | 13 May 2025 | 00:19:07 | |
In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses tailoring contraceptive use in certain populations based on updated US medical eligibility criteria, patient preferences, and medical history. This is an excerpt from our October 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Managing Conjunctivitis | 22 Apr 2025 | 00:19:33 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses the treatment of conjunctivitis, or pink eye. This is an excerpt from our July 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| To Vitamin D or Not to Vitamin D? | 08 Apr 2025 | 00:15:04 | |
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, answers the question… To Vitamin D or Not to Vitamin D? That’s right, this episode we explore the latest guidelines on Vitamin D Supplementation. This is an excerpt from our October 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Epinephrine for Anaphylaxis | 25 Mar 2025 | 00:15:48 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, explains how the recently approved epinephrine nasal spray compares to the injectable products for treating anaphylaxis. This is an excerpt from our October 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Ensifentrine (Ohtuvayre) for COPD | 11 Mar 2025 | 00:10:54 | |
In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS, discusses a new drug for COPD, ensifentrine (Ohtuvayre). This is an excerpt from our September 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Managing Diabetes Meds Around Surgery | 25 Feb 2025 | 00:15:42 | |
In this episode, TRC Healthcare editor, Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, discusses the management of diabetes meds around surgery. This is an excerpt from our November 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Flu Vaccine Guidance for 2025-2026 | 11 Nov 2025 | 00:19:48 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, dives into the 2025/2026 flu vaccine season with a clear overview of what’s new and what remains consistent. From updated vaccine strain compositions and preferred products for older adults to thimerosal-free recommendations and egg allergy guidance, this episode equips you with the latest evidence-based insights. ****** CE Information: ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
10% off a new or upgraded subscription with code cc1025 at checkout. 🎓 Student free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Managing Resistant Hypertension | 11 Feb 2025 | 00:16:38 | |
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, discusses the management of resistant hypertension. This is an excerpt from our December 2024 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Don’t miss out! Subscribe to Pharmacist’s Letter today to stay ahead with trusted insights and tools. If you're a student, good news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Pneumococcal Vaccine Recommendations | 28 Jan 2025 | 00:20:48 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses Pneumococcal Vaccine Recommendations for Adults.
Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Buprenorphine for Opioid Use Disorder (OUD) | 28 Oct 2025 | 00:15:23 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses how pharmacists and pharmacy technicians play a vital role in ensuring access to buprenorphine for opioid use disorder treatment. She’ll explore approaches to addressing dispensing barriers, inventory management strategies, and the importance of recognizing opioid use disorder as a chronic condition requiring appropriate long-term care. This is an excerpt from our March 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Don’t Let New Meds for Acute Migraine Give You a Headache | 14 Oct 2025 | 00:16:25 | |
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, evaluates 3 new migraine treatments: Atzumi, Brekiya, and Symbravo. She'll explain their dosing techniques and how they compare to existing therapies, while providing practical guidance on clinical considerations and cost-effective alternatives for acute migraine management. This is an excerpt from our August 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Explore Different Med Regimens for H. pylori | 23 Sep 2025 | 00:15:01 | |
In this episode, TRC Healthcare editor, Rachel Cole, PharmD, unpacks the updated recommendations for H. pylori management, spotlighting why bismuth quadruple therapy is now front and center and how to navigate antibiotic resistance and patient-specific factors. You’ll come away with actionable pearls on regimen selection, adherence strategies, and which drug interactions to watch for. This is an excerpt from our February 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Pain Management Update: Meet Suzetrigine (Journavx) | 09 Sep 2025 | 00:11:27 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, digs into Suzetrigine—brand name Journavx—the first non-opioid analgesic approved in over two decades. You’ll hear how it works, how it compares to hydrocodone/acetaminophen, and why it might be a game-changer for patients at risk of opioid misuse. We’ll also unpack limitations in the clinical trials, cost concerns, dosing nuances, and key drug interactions to watch for. Plus, we’ll share tips for counseling patients and navigating formulary decisions, especially if your site participates in the manufacturer’s pilot program. Don’t miss our quick skim graphic and comparison resource to help you make informed decisions. This is an excerpt from our April 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| New Twists to Old Meds: Fresh Formulations of Losartan, Minocycline, and More | 26 Aug 2025 | 00:18:49 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, discusses recently approved drug formulations that bring fresh options—and new challenges—to the pharmacy counter. From Arbli, the first ready-to-use losartan suspension, to Emrosi, a low-dose minocycline for rosacea, and Opipza, an oral film version of aripiprazole, we’ll walk through what makes each product unique and what pharmacy teams should watch for. We also cover HemiClor, a 12.5 mg chlorthalidone tablet that may help patients avoid splitting unscored tabs, Neffy, a needle-free epinephrine nasal spray now available in a pediatric strength, and wrap up with biosimilar updates on Merilog and Omlyclo. This is an excerpt from our June 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Use code cc1025 at checkout for 10% off a new subscription. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Zepbound for Zzz’s: Exploring Tirzepatide for Sleep Apnea | 12 Aug 2025 | 00:13:55 | |
In this episode, TRC Healthcare editor, Sara Klockars, PharmD, BCPS unpacks the newly approved use of tirzepatide (Zepbound) for obstructive sleep apnea (OSA)—a first-in-class pharmacologic option for a condition long managed with devices and lifestyle changes. You’ll hear a concise review of sleep apnea pathophysiology, how tirzepatide works to reduce airway obstruction, and what the latest clinical trials reveal about its efficacy and safety. Plus, you’ll get practical pharmacy-focused insights on side effect management, payer considerations, and how to avoid duplicate GLP-1 therapy. This is an excerpt from our April 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. **** GLP-1 Essentials from TRC Healthcare – Now Available Master the essentials of GLP-1 therapy with this focused GLP-1 agonists CE bundle. Get 4 hours of CE plus clinical tools to help you prescribe, titrate, switch therapies, and support patients confidently. Courses include:
Now included with Pharmacist’s Letter Platinum and Diamond subscriptions, or available as a standalone CE experience. **** Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Biosimilars 101 | 22 Jul 2025 | 00:14:35 | |
In this episode, TRC Healthcare editor, Vickie Danaher, PharmD, guides listeners through the evolving landscape of biosimilars, highlighting their increasing presence in pharmacy practice and their critical distinctions from traditional generics. She explains the science behind biologics, the FDA’s rigorous approval process for biosimilars, and the nuances of interchangeability. With examples of biosimilars for Stelara, Humira, and Prolia, Vickie illustrates how pharmacists can confidently counsel patients, verify product details, and stay compliant with state laws. Whether you're stocking shelves or answering patient questions, this episode equips you with the knowledge to handle biosimilars with confidence, precision, and care. This is an excerpt from our January 2025 Pharmacy Essential Updates continuing education webinar series. The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code podcast1025 at checkout for 10% off a new subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Hypothyroidism Meds: Answers to Common Questions | 10 Feb 2026 | 00:15:28 | |
Managing hypothyroidism often seems straightforward—but the details can make all the difference. In this episode, Rachel Cole, PharmD, shares actionable pearls for pharmacy teams, such as how to handle levothyroxine product switches, when to monitor TSH, and tips for counseling patients on adherence. Plus, we’ll tackle common myths, explore safety concerns with desiccated thyroid extract (DTE), and review FDA’s recent alert. Get clear answers, practical counseling tips, and monitoring strategies you can use today. This is an excerpt from our November 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. ***** 📣 New Podcast!📣 🌱Natural Medicines: Evidence in Practice Evidence, not hype. Concise, clinician‑ready guidance on natural medicines and integrative care. Episode 1: GLP‑1s & Nutrition is live now! ***** Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| What’s New in Acute Sinusitis: Antibiotics vs. Watchful Waiting | 27 Jan 2026 | 00:14:45 | |
Think every sinus infection needs an antibiotic? Think again. Updated guidelines for acute bacterial rhinosinusitis are sparking discussions about when antibiotics are truly warranted—and pharmacy teams play a key role in helping guide practice. In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, explains new recommendations for “watchful waiting,” when to initiate antibiotics, supportive care measures to try, and more. You’ll also hear practical pearls on first-line therapy, dosing strategies for amoxicillin and amoxicillin/clavulanate, and safe alternatives for penicillin-allergic patients. Plus, Gina shares tips for counseling patients and reducing antibiotic resistance while improving outcomes. This is an excerpt from our December 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Helping Patients Quit Vaping | 13 Jan 2026 | 00:14:01 | |
Vaping is more popular than ever, especially among young adults, and pharmacy teams are in a prime position to guide patients toward cessation. In this episode, TRC Healthcare editor, Gina Corley, PharmD, breaks down the health risks of vaping and shares unique barriers to vaping cessation. She also discusses how proven smoking cessation strategies (varenicline, nicotine replacement therapy, and bupropion) may work to help patients quit vaping. Plus, you’ll hear about counseling points and free resources to support patients in their quit journey. This is an excerpt from our September 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Preventing Respiratory Syncytial Virus (RSV): Immunization Updates | 23 Dec 2025 | 00:20:16 | |
RSV prevention is more important than ever, and pharmacy teams are on the front lines. In this episode, TRC Healthcare Associate Editor, Vickie Danaher, PharmD, reviews who should receive RSV vaccines, recent changes to age and risk-based recommendations, and how monoclonal antibodies protect infants and high-risk children. You’ll also hear practical tips on the best time to vaccinate patients, co-administration with other vaccines, product nuances, and safety considerations to help confidently guide patients through RSV prevention this season. This is an excerpt from our October 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1025 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Managing Opioid Overdose: Signs, Symptoms, and Reversal Agents | 24 Mar 2026 | 00:18:25 | |
Opioid overdoses remain a leading cause of preventable death - and pharmacy teams are on the front lines of response. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, discusses how to recognize opioid overdose, compares naloxone and nalmefene options including the new nalmefene auto-injector, and shares tips for counseling patients and caregivers on using opioid reversal agents effectively. This is an excerpt from our December 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Treating Dry Eye Disease: A Look at Today’s Medications | 10 Mar 2026 | 00:15:12 | |
Dry eye disease affects millions of patients, yet the growing list of treatment options can make decision-making feel more complicated than ever. Treating dry eyes requires understanding not just what options are available, but where each one fits into therapy. In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, walks through the causes of dry eye disease and breaks down today’s treatment landscape, from OTC artificial tears to prescription options like cyclosporine, lifitegrast, and newer therapies. She highlights how these medications work, where they fit in therapy, and practical counseling tips to help patients get relief. This is an excerpt from our November 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| First-Time Rx Oral Liquids for Common Meds | 24 Feb 2026 | 00:16:35 | |
New oral liquids are hitting the market – here's what to expect for your pharmacy. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses a growing wave of first-time oral liquid formulations for familiar medications, including ADHD therapies, diabetes meds, antihypertensives, and more. She breaks down why these liquid options are emerging, which patients may benefit most, and what pharmacists and technicians need to watch for when dispensing. You’ll hear practical insights on dosing, storage, and stability, along with counseling pearls and pitfalls that commonly lead to medication errors. Plus, Vickie highlights cost considerations and key distinctions between liquid products and their tablet or capsule counterparts, helping pharmacy teams stay ahead as these formulations become more common in practice. This is an excerpt from our November 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. Use code cc1026 at checkout for 10% off a new or upgraded subscription. ***** 📣 New Podcast!📣 🌱Natural Medicines: Evidence in Practice Evidence, not hype. Concise, clinician‑ready guidance on natural medicines and integrative care. Episode 1: GLP‑1s & Nutrition is live now! ***** Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Semaglutide Becomes the First ORAL GLP-1 Approved for Weight Loss | 14 Apr 2026 | 00:15:18 | |
A new oral option is changing the GLP-1 landscape for weight loss, along with raising questions about efficacy, dosing, and when switching products makes sense. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD discusses how semaglutide became the first FDA-approved oral GLP-1 agonist for obesity. She breaks down how it works, how it compares to injectable options, and dosing considerations for patients. Vickie also walks through key counseling points around administration, side effects, cost, and product mix-ups, and offers practical guidance on when switching between injectable and oral semaglutide may or may not be the right choice. This is an excerpt from our February 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Hair Loss in Men: Treating Male Pattern Baldness | 28 Apr 2026 | 00:20:40 | |
Male pattern baldness is more than a cosmetic concern – and patients often turn to the pharmacy first for answers. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, discusses treating male pattern baldness. He reviews the underlying mechanism of hair loss and compares evidence-based treatment options, including oral finasteride, topical minoxidil, and more. Don also provides practical counseling points, including adverse effects, expected timelines for hair regrowth, and why the effects are typically not permanent once treatment is stopped. This is an excerpt from our January 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Advanced Therapies for Crohn Disease: Biologics and JAK Inhibitors | 09 Jun 2026 | 00:15:46 | |
New guidelines for moderate to severe Crohn disease help streamline more advanced therapy options, such as biologics and JAK inhibitors. In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, walks through the latest guideline updates for moderate to severe Crohn disease. She breaks down advanced therapy options such as biologics and JAK inhibitors, discusses how factors like prior biologic exposure shape treatment decisions, and where immunomodulators and steroids fit in. This is an excerpt from our March 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Updated COPD Guidelines: Strategies for Treatment and Management | 26 May 2026 | 00:19:18 | |
Updated COPD guidelines are reshaping how soon patients start daily inhalers—and what therapies make the most sense based on symptoms and risk. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, reviews practical, guideline-based strategies for treating and managing chronic obstructive pulmonary disease (COPD). Don highlights common factors that increase exacerbation risk and explains how current recommendations aim to better match therapy to patient needs. He also clarifies key differences between COPD and asthma, walks through the main goals of COPD management, and reviews where short- and long-acting bronchodilators, as well as inhaled corticosteroids, fit into care. The discussion includes when to escalate treatment, common inhaler technique mistakes that limit effectiveness, and non-drug strategies that can help keep patients out of the hospital. In this episode, you’ll hear about:
This is an excerpt from our February 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Beyond the Cuff: Measuring and Monitoring Blood Pressure | 12 May 2026 | 00:16:28 | |
Blood pressure is one of the most commonly measured — and most commonly misread — vitals in healthcare. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how pharmacists and pharmacy technicians can help patients better manage hypertension. She goes over how to choose the right home blood pressure monitor, ways to use it correctly, and tips for getting the most accurate readings. This is an excerpt from our March 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Navigating the Medicare GLP-1 Bridge: What Pharmacy Teams Need to Know | 30 Jun 2026 | 00:14:24 | |
GLP-1 access just changed for Medicare patients—and pharmacy teams are on the front lines. In this BONUS episode, Associate Editor and Clinical Pharmacist Vickie Danaher breaks down the new Medicare GLP-1 Bridge program—what it is, how it works, and what pharmacy teams need to know right now. Get a clear overview of which GLP-1 medications are covered, who qualifies, and how to navigate key requirements like prior authorization and claim routing. She also covers common points of confusion—like how the program differs from Medicare Part D, what the $50 copay actually means for patients, and what to watch for at the pharmacy counter. If you’re fielding questions about GLP-1 access or preparing your team for this new CMS program, this episode will help you stay ahead and avoid workflow headaches. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Help Patients Use Continuous Glucose Monitors Safely and Effectively | 23 Jun 2026 | 00:22:00 | |
Continuous glucose monitoring is changing how diabetes is managed, and healthcare teams are at the center of helping patients use these devices safely and effectively. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how continuous glucose monitoring has helped improve diabetes care. She talks about how CGM devices work, which patients are good candidates, prescription vs. OTC options, and when guidelines recommend their use. This is an excerpt from our April 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||
| Orforglipron Explained: A New Oral GLP-1 for Weight Loss | 14 Jul 2026 | 00:19:56 | |
New oral GLP-1s are changing the weight loss game. Here is what you need to know before recommending or dispensing one. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more. This is an excerpt from our May 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:
Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. Email us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com. | |||